The transformative capacity of cells as therapeutics has revolutionised malignancy treatments.1 Cellular engineering advances ...

The first pneumococcal conjugate vaccine (PCV) was licensed more than 25 years ago in the USA and Europe, but its marketing authorisation was based on efficacy studies using a 3+1 dosing regimen, ...

HIV self-testing, which has been increasingly available since 2016, can substantially enhance the uptake of HIV testing, especially for key populations. Clinical trials have explored the application ...

The intergenerational impact of violence is an emerging focus in research, with growing recognition that there is a substantial knowledge gap, especially in low-income and middle-income countries ...

This year's recipients have been recognised for their work on the HIV epidemic, GLP-1-based drugs, and how DNA can stimulate ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

As the year 2030 approaches, the prospects of achieving the Sustainable Development Goal (SDG) agenda, especially the SDG 2 (Zero Hunger), seem increasingly difficult. Numerous and interlinked crises ...

The health system has been decimated. Although violence has fallen, emergency funding is still well short of needs. Sharmila ...

The full and ugly truth about England's population health and the performance of its National Health Service (NHS) will not ...

There are some politicians who get involved in health and have to reverse-engineer a narrative about their life and the ...

Medical Experimentation and the Price of Saying No, Carl Elliott describes how he found himself careening through one of those unwelcoming inner courtyards that you find in large hospital centres.

In the natural history of chronic liver diseases, development of portal hypertension is the earliest complication, with clinically significant portal hypertension (CSPH) being the key driver of ...